Advanced rectal tumors can be treated with curative intent by surgical resection of the rectum including other pelvic organs. The reconstruction of the urinary and gastrointestinal tracts depends on the distance between the tumor and the anus, the patient's status and the experience of the surgical team. This is a case of a male patient with a locally advanced low rectal tumor that underwent a laparoscopic pelvic exenteration. The anus and the tumor and other organs were excised by peritoneal approach. The uretero-colic anastomosis was performed extra-abdominally. The patient was discharged on the 14 th postoperative day and remains healthy six months after the surgery. This approach has shown to be feasible and safe. The aesthetical result was well accepted by the patient. The laparoscopic route should be considered as an alternative approach to pelvic exenteration in the treatment of locally advanced low rectal tumors that demand perineal amputation.Keywords: rectal neoplasm; pelvic exenteration; laparoscopy. RESUMO:O tumor de reto localmente avançado pode ser tratado com intenção curativa com uma operação ampliada que inclua outros órgãos da pelve. A reconstrução do trânsito urinário e do trânsito intestinal dependerá da distância do tumor em relação à margem do ânus, da experiência da equipe de cirurgiões, assim como das morbidades associadas do paciente. Apresentou-se neste artigo o caso de um paciente do sexo masculino, com tumor de reto baixo localmente avançado que foi submetido à exenteração pélvica por laparoscopia. Houve indicação para ressecção do ânus e a peça cirúrgica foi retirada por via perineal. A anastomose uretero-colônica foi confeccionada de maneira extracorpórea. O paciente recebeu alta hospitalar após 14 dias e encontra-se com seis meses pós-operatórios. O método se mostrou factível e seguro. O resultado estético foi bem aceito pelo paciente. A via de acesso laparoscópica pode ser considerada uma alternativa para a exenteração pélvica no tratamento do tumor de reto baixo avançado que necessita de amputação anoperineal.Palavras-chave: neoplasia de reto; exenteração pélvica; laroscopia.
Crohn's disease (CD) is a chronic, relapsing, idiopathic condition, characterized by granulomatous, transmural inflammation of the gastrointestinal tract, which can affect its entire length, from mouth to anus. Metastatic Crohn's disease (MCD) is a rare form of skin involvement and is defined by skin lesions without contiguity with the gastrointestinal tract. A 9-year-old patient presented with gastrointestinal complaints and gross skin lesions in the vulva and perianal region. The diagnosis of Crohn's disease was made when the patient was 11 years old, after being evaluated by the colorectal surgeon. Treatment was started with a “top-down” approach, with a sustained response for four years. Afterwards, there was a relapse of the skin disease in previously normal areas, without overt symptoms. Treatment consisted of steroids and local infiltration of infliximab, without improvement. A year later, there was a rapid progression of the skin lesions, and the drug changed to adalimumab, also without response and worsening of the skin lesions. The patient was admitted to the hospital and intravenous steroids were initiated, along with surgical debridement of the lesions. After some improvement, ustekinumab was initiated with satisfactory response. Pediatric MCD has an important impact on the patient's quality of life, with influences on growth and social development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.